Group 1 - Beta Bionics is under investigation by Pomerantz LLP for potential securities fraud or unlawful business practices involving its officers and/or directors [1] - On January 8, 2026, Beta Bionics reported a 36% year-over-year increase in new patient starts for Q4 2026, a decline from the 68% increase in the previous quarter [2] - Following the financial results announcement, Beta Bionics' stock price dropped by $11.85 per share, or 37.03%, closing at $20.15 per share on January 9, 2026 [2] Group 2 - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of recovering multimillion-dollar damages for victims of securities fraud [3]

Core Viewpoint - Hagens Berman is alerting investors about a pending class action against CoreWeave, Inc. for allegedly misleading the market regarding its AI infrastructure scalability and revenue guidance [1][4] Allegations of Misrepresentation - The lawsuit claims that CoreWeave overstated its capacity to meet customer demand and downplayed operational risks associated with reliance on a single third-party data center supplier [2][7] - Significant delays at the Denton, Texas data center have been revealed, which were reportedly months behind schedule, leading to a market capitalization drop of approximately $14 billion [2][7] Market Reaction - Following the company's lowered guidance, there was a notable stock drop of 16% on November 11, contributing to a significant loss in shareholder value [7] Investigation Details - Reed Kathrein, the partner leading the investigation, emphasized the gap between the company's growth assurances and the reality of construction delays at its primary data center sites [3][4] - The complaint alleges that CoreWeave's ability to recognize revenue from its multibillion-dollar backlog was contingent on infrastructure that was not on track for timely completion [7] Next Steps for Investors - Investors who purchased CoreWeave shares during the Class Period (March 28, 2025 – December 15, 2025) and suffered losses are encouraged to submit their claims [5][6]

BENSALEM, Pa., Jan. 22, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ARDENT HEALTH, INC. (ARDT), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT. Contact the Law Offices o ...

LOS ANGELES, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming February 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Blue Owl Capital Inc. (“Blue Owl” or the “Company”) (NYSE: OWL) securities between February 6, 2025 and November 16, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR OWL INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CL ...

Core Viewpoint - StubHub Holdings, Inc. is facing a class action lawsuit due to alleged misleading statements in its registration statement related to its September 2025 IPO, particularly concerning its financial performance and cash flow issues [1][6]. Financial Performance - StubHub conducted its IPO on September 17, 2025, selling approximately 34 million shares at $23.50 per share [2]. - In the third quarter of 2025, StubHub reported a free cash flow of negative $4.6 million, a 143% decrease from the previous year's positive free cash flow of $10.6 million [3]. - The company's net cash provided by operating activities was $3.8 million, down 69.3% from $12.4 million in the same period the previous year [3]. - Following the financial results announcement, StubHub's stock price dropped by $3.95, or 20.9%, closing at $14.87 on November 14, 2025 [4]. - By the time the lawsuit commenced, StubHub's stock had fallen to $10.31 per share, representing a nearly 56% decline from the IPO price [5]. Lawsuit Details - The class action lawsuit alleges that the registration statement was materially false and misleading, failing to disclose significant adverse facts about the company's operations and cash flow [6]. - Specific allegations include undisclosed changes in vendor payment timing that adversely affected free cash flow, leading to misleading financial reports [6]. - Investors who purchased StubHub common stock in connection with the IPO are encouraged to file a lead plaintiff motion by January 23, 2026 [7].

Core Viewpoint - A class action lawsuit has been filed against Fermi Inc. and its executives due to significant stock price drops linked to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as claims under Sections 11 and 15 of the Securities Act of 1933 [3]. - Investors have until March 6, 2026, to request to lead the case, which is pending in the U.S. District Court for the Southern District of New York [3]. Group 2: Company Background - Fermi Inc. is an energy and AI infrastructure company aiming to build large-scale nuclear reactors to support grid-independent data centers for AI companies [4]. - The company's flagship project, Project Matador, is designed to provide dedicated power for AI workloads [4]. Group 3: IPO and Allegations - Fermi completed its IPO in October 2025, claiming strong demand for Project Matador and securing a 20-year lease with an investment-grade-rated tenant [5]. - Allegations suggest that Fermi overstated tenant demand and misrepresented the agreement with the First Tenant [6]. Group 4: Stock Price Impact - On December 12, 2025, Fermi's stock dropped by $5.16 per share, over 33%, following the termination of the Advance in Aid of Construction Agreement by the First Tenant [7].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Group 1: Lawsuit Details - The lawsuit is based on claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, representing investors in Alexandria Real Estate securities [3]. - The case is currently pending in the U.S. District Court for the Central District of California, titled Hern v. Alexandria Real Estate Equities, Inc., et al., No. 2:25-cv-11319 [3]. Group 2: Company Background - Alexandria Real Estate is a real estate investment trust (REIT) primarily focused on tenants in life science industries, including pharmaceutical and biotechnology companies [4]. Group 3: Financial Performance and Stock Impact - Alexandria Real Estate reported lower-than-expected results for Q3 2025, leading to a stock price drop of $14.93 per share, or over 19%, from $77.87 to $62.94 between October 27 and October 28, 2025 [6]. - The company announced a real estate impairment charge of $323.9 million, with $206 million attributed to its Long Island City property, which was deemed not suitable for life science scaling [5][6]. - Additional impairment charges may be recognized in Q4 2025, ranging from $0 to $685 million [6].

New York, New York--(Newsfile Corp. - January 21, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Bgin Blockchain Limited ("Bgin Blockchain Limited") (NASDAQ: BGIN) concerning potential violations of the federal securities laws.Bgin released unaudited financial results on November 14, 2025, for the six months ended June 30, 2025, revealing that total revenue had declined roughly $96 million from the previous year, operating expenses increased 582.8%, and the Company' ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming March 13, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired CoreWeave, Inc. ("CoreWeave†or the "Company†) (NASDAQ: CRWV) securities between March 28, 2025 and December 15, 2025, inclusive (the "Class Period†). However, on October 30, 2025, Core Scientific announced that it had not received enough shareholder votes to approve the merg ...

New York, New York--(Newsfile Corp. - January 21, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Wealthfront Corporation (NASDAQ: WLTH) for potential violations of the federal securities laws. If you invested in Wealthfront, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/wealthfront-corporation-class-action.Why is Wealthfront Being Investigated for Violations of the Federal Securities Laws? Wealthfront is an onli ...